Galantamine: Difference between revisions
From Proteopedia
Jump to navigationJump to search
David Canner (talk | contribs) New page: <applet load="" size="480" color="" frame="true" spin="on" Scene ="Donepezil/Donepezil/1" align="right" caption="Tacrine, also known as Cognex"/> ===Better Known as: Namenda=== * Market... |
David Canner (talk | contribs) No edit summary |
||
| Line 5: | Line 5: | ||
* Drug Class: [[Acetylcholinesterase]] Inhibitor | * Drug Class: [[Acetylcholinesterase]] Inhibitor | ||
* Date of FDA Approval (Patent Expiration): <br /> | * Date of FDA Approval (Patent Expiration): <br /> | ||
* 2006 Sales: $650 Million | * 2006 Sales: $650 Million<ref>Irena Melnikova, Therapies for Alzheimer's disease, Nature Reviews Drug Discovery 6, 341-342 (May 2007)</ref> | ||
* Why You Should Care: One of the the first treatments for the symptoms of [[Alzheimer's Disease]], although no definitive proof exists as to whether to alters the progression of the disease. | * Why You Should Care: One of the the first treatments for the symptoms of [[Alzheimer's Disease]], although no definitive proof exists as to whether to alters the progression of the disease. | ||
* The following is a list of Pharmacokinetic Parameters. See: [[Pharmaceutical Drugs]] for more information | * The following is a list of Pharmacokinetic Parameters. See: [[Pharmaceutical Drugs]] for more information | ||
